Lupin best pick among pharma stocks, see 5-15% upside: Mehraboon Irani

Mehraboon Irani, Independent Market Expert told CNBC-TV18, "I continue to remain negative on the pharma pack and I reiterate what I had mentioned possibly just a week or two weeks ago, that I personally believe that most of the pharma stocks should trade – people should be trading long."

"I personally believe in Lupin, I will not be surprised if you see a price of Rs 1300-1400 again coming over the next one to three months. However as far as investment goes and if somebody wants to buy for the longer term, I am still completely off pharma like what I have been over the last 2-3 years."

"So, Lupin according to me is a best pick in the pharma pack if somebody is looking for a trade of 5-15 percent on the upside over the next 1-3 months," he added.